Login
$SOPH
$7.54 +$0.02 (0.27%) Close

$SOPH 4 SEC Filings

Filed On Filing
14 Oct 2026 Form 4: Menu Philippe, Chief Medical Officer

Sold 5,000 shares ($36.3K)

14 Oct 2026 Form 4: Xu Zhenyu, Chief Scientific Officer

Sold 4,000 shares ($28.7K)

14 Oct 2026 Form 4: Camblong Jurgi, Director

Sold 8,500 shares ($61.7K)

07 Oct 2026 Form 4: Van Well Daan, Chief Legal Officer

Sold 6,168 shares ($50.1K)

07 Oct 2026 Form 4: Valente Manuela, Chief People Officer

Sold 4,240 shares ($34.5K)

07 Oct 2026 Form 4: Verma Abhimanyu, Chief Technology Officer

Sold 5,284 shares ($42.9K)

07 Oct 2026 Form 4: Puylaert Kevin, Chief Sales Officer

Sold 216 shares ($1.74K)

07 Oct 2026 Form 4: Cardoza George, Chief Financial Officer

Sold 1,592 shares ($12.9K)

07 Oct 2026 Form 4: Menu Philippe, Chief Medical Officer

Sold 7,394 shares ($60.1K)

07 Oct 2026 Form 4: Camblong Jurgi, Director

Sold 40,172 shares ($327K)

07 Oct 2026 Form 4: Xu Zhenyu, Chief Scientific Officer

Sold 7,394 shares ($60.1K)

07 Oct 2026 Form 4: Muken Ross, Director

Sold 9,838 shares ($80K)

22 Sep 2026 Form 4: Cardoza George, Chief Financial Officer

Sold 774 shares ($6.45K)

22 Sep 2026 Form 4: Muken Ross, Director

Sold 422 shares ($3.52K)

16 Sep 2026 Form 4: Menu Philippe, Chief Medical Officer

Sold 5,000 shares ($39.4K)

16 Sep 2026 Form 4: Xu Zhenyu, Chief Scientific Officer

Sold 4,000 shares ($31.5K)

14 Sep 2026 Form 4: Van Well Daan, Chief Legal Officer

Sold 6,168 shares ($47.1K)

14 Sep 2026 Form 4: Camblong Jurgi, Director

Sold 8,500 shares ($65.1K)

10 Sep 2026 Form 4: Hibbs Kathy L, Director

Sold 6,250 shares ($50.8K)

31 Aug 2026 Form 4: Xu Zhenyu, Chief Scientific Officer

Sold 10,000 shares ($89.1K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support